Skip to content
★ Sign in to follow
LM

Lepu Medical Technology (Beijing) Co., Ltd. Stock: price and insider trades · China

乐普医疗

CN·Mcap CN¥23.2BHealth Care

1 insider bought €1.3M of shares over the last 90 days, the latest by 蒲忠杰, filed 24 Aug 2026.

Lepu Medical Technology (Beijing) Co., Ltd.: what insiders have been doing

Lepu Medical Technology (Beijing) Co., Ltd. is a Health Care company. Its directors and officers file their transactions with SSE / SZSE (CSRC). In the past year (7 November 2025 to 7 November 2026), 1 filing came from 1 insider.

Only purchases show up on the open market, 1 purchase in all worth €1.3M, filed by 1 insider. Unlike grants, an open-market purchase is paid for by the insider, at the market price. On the buying side, the filings list 1 chief executive among the declarants. At €1.3M, the purchase published on 24 August 2026 by 蒲忠杰 is the largest of the period.

Across the 522 companies tracked on its exchange, the median is 2 filings; at 1 filing, this issuer sits below that mark. The full history, which starts in 2022, counts 1 purchase against 1 sale.

The clock since the last published purchase (24 August 2026) now reads 76 days.

Other companies in the same sector with recent insider buying flagged by our signals: Dynavox Group AB and Vetoquinol SA. This summary is built from SSE / SZSE (CSRC) disclosures alone and does not predict where the share price will go.

Insider Decl.
2
Thresholds
n/a
Buy Volume
€1M
1 ops. · all time
Sell Volume
€30,206
1 ops. · all time

Who traded when

BuySale
蒲忠杰1 buy

Since the insiders bought

  • Filed 24 Aug 2026 · 76 days ago · €1.3M
    +5.4%
    Entry CN¥11.94 · Close 05 Nov 2026 CN¥12.58

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Analyst consensus: bullish or bearish?

Analysts rate Lepu Medical Technology (Beijing) Co., Ltd. Strong Buy (bullish), based on 3 analysts. Average price target: CN¥19.58.

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 11,759 of 26,912 companies
54.8
score / 100
Value
51
Quality
59
FCF yld3.8%
Earn yld4.1%
EV/EBITDA14.6x
ROE3.5%
Gross mgn64%
Net mgn15%
Debt/EBITDA3.1x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

CN¥12.59
Analyst consensus
3 analysts
Strong buy
CN¥11.90Target CN¥19.58(+56%)CN¥24.00
Income statement
RevenueCN¥6.5B
Gross profitCN¥4.1B64% margin
EBITDACN¥2B31% margin
Net incomeCN¥962M10.7% margin
Valuation
PER (trailing)35.0x
P/Book1.4x
Beta0.05
Balance sheet & cash
Market capCN¥23.2B
Total debtCN¥6.4B
Free Cash FlowCN¥873.9M
Debt / Equity35%
Profitability & ownership
ROE3.5%
ROA1.9%
% insiders38.5%
% institutions6.7%
Last declaration on 24 August 2026
Declarations2 total
  • ▲
    董事长Executives
    10M CNY33SZSE
    853,700 shares@ CN¥91.9059100.0% of flowA股XSHESZSE:273000001351288420
    Canonical exit: 22 Nov 2026 (T+90)
  • ▼
    高级副总经理Executives
    212,400 CNY30SZSE
    10,000 shares100.0% of flowA股XSHESZSE:173000005552417200

2 of 2 declarations

About Lepu Medical Technology (Beijing) Co., Ltd.

乐普医疗 is a company specializing in the healthcare and pharmaceutical sector, providing innovative solutions for medical diagnosis and treatment. It is listed on the XSHE market.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations